NUCLEOLIN and familial pancreatic carcinoma: In conclusion, our study demonstrates the influence of altered O-glycan (Tn/STn) expression on oncogenic properties in pancreatic cancer and identifies O-GalNAc modified Nucleolin as novel prognostic marker.